$30 Million Medical Office Startup Borrows from Netflix, Apple

By Mary Kate Nelson | Medical Office News

Imagine a doctor’s office that looks like an Apple Store, bills patients like Netflix, and incorporates Silicon Valley-approved talent and artificial intelligence (AI). All of that’s a reality at Forward, a San Francisco-based medical startup that opened to the public on Tuesday.

To put it simply, Forward is “a doctor’s office that feels more like an Apple Store,” Forward CEO Adrian Aoun said, according to CNNMoney. “An Apple Store that learns so it gets better with more data.”

The concept, in its entirety, is much more complex.

The 40-person startup occupies a 3,500-square-foot space in San Francisco with six examination rooms, a lab and state-of-the-art health care technology onsite. Forward charges “members,” or patients, $149 per month for unlimited appointments and email conversations with primary care physicians brought on board from Sutter Health, Stanford Hospitals and Kaiser Permanente. Continuous patient monitoring via wearable devices, as well as some supplements and medications, are also included in the flat fee.

The aim of Forward is to change the primary health care model to a continuous relationship between patient and health care provider, with a strong emphasis on wellness and prevention—not to impress millennials, Aoun told Forbes.

“Health care is not a repair shop but an ongoing relationship,” Aoun explained, according to USA Today.

The patient on-boarding process at Forward is unique, too. First-time patients are checked in using an iPad before visiting a full-body scanner, which records and sends their health care data to Forward’s AI algorithms. New patients also undergo genetic and blood testing.

So far, a few hundred people have signed up as Forward “members,” Forbes reported. Approximately 15% of these patients live in underserved communities and their memberships are either free or subsidized.

Continue Reading Article


All information contained in this publication is derived from sources that are deemed to be reliable. However, Newmark has not verified any such information, and the same constitutes the statements and representations only of the source thereof, and not of Newmark. Any recipient of this publication should independently verify such information and all other information that may be material to any decision that recipient may make in response to this publication, and should consult with professionals of the recipient's choice with regard to all aspects of that decision, including its legal, financial, and tax aspects and implications. Any recipient of this publication may not, without the prior written approval of Newmark, distribute, disseminate, publish, transmit, copy, broadcast, upload, download, or in any other way reproduce this publication or any of the information it contains. This document is intended for informational purposes only and none of the content is intended to advise or otherwise recommend a specific strategy. It is not to be relied upon in any way to predict market movement, investment in securities, transactions, investment strategies or any other matter.

Download Our

Sign Up for Our Newsletter